Scientists continue to investigate how cannabinoids may interact with the immune system, especially in conditions involving chronic inflammation and autoimmune responses. In the review “Cannabinoids in autoimmune diseases: mechanistic insights and translational challenges,” researchers examined how cannabinoids may influence immune pathways connected to autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, lupus, and type 1 […]
Tag: multiple sclerosis
Non-Psychotropic Cannabinoids Continue Showing Promise in Neuroinflammation Research (Pub. April 2026)
Scientists continue studying how hemp-derived cannabinoids may support the body’s response to neuroinflammation and neurodegenerative conditions. In the review “Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration,” researchers examined how cannabinoids such as CBD, CBG, and CBC interact with microglia — the immune cells of the central nervous […]
CBD Demonstrates Neuroprotective Effects in Neurodegenerative Disease Research (pub. July 2024)
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s, multiple sclerosis, and ALS involve the progressive loss of neurons, leading to declines in memory, movement, and overall brain function. These conditions are linked to factors like aging, chronic inflammation, oxidative stress, and abnormal protein buildup in the brain. Traditional treatments often provide only short‑term symptom relief and […]